zepbound and tirzepatide FDA Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea Eli Lilly's weight loss, diabetes

When companies need products, they cant wait around

Sublingual oral dissolving tablets administer the medication under the tongue without the need for needles

doi: 10.1016/j.diabres.2024.111617, 133 SikiricaM

Why such high doses are needed: Leucovorin relies almost entirely on the RFC pathwaythe route that normally provides only 5% of folate transport The major pathways (FR and PCFT, representing 85-95% of transport) remain blocked by folic acid and dairy antibodies Oxidative stress further impairs RFC function by 20-40% Low vitamin D limits RFC capacity The results: 70-100% of children with CFD show improvement when treated early (before age 6) 30-50% of children with neurodevelopmental disorders experience moderate to substantial improvement BUT: Many experience headaches, irritability, insomnia, and hyperactivity 30-50% show limited or no improvement The irony: We're forcing 5,000-50,000 mcg through a 5% pathway while ignoring the blocked highways that should handle 85-95% of transport

Many people worry about putting weight back on after going off the medication